PATENT CLAIM ANALYSIS

Application Number: 16223925
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["546", "119000"]

Abstract:
The invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.

Claim (Index 9):
The compound according to  claim 1 , wherein\n R 2  represents\n \u2014C(\u2550O)\u2014C 1-10 -alkyl, unsubstituted or mono- or disubstituted with substituents independently of one another selected from the group consisting of \u2014F, \u2014Cl, and \u2014Br; \n \u2014C(\u2550O)-cyclopropyl, unsubstituted or mono- or disubstituted with substituents independently of one another selected from the group consisting of \u2014F, \u2014Cl, \u2014Br, \u2014CH 3 , \u2014CF 3 , \u2014CN, and \u2014OCH 3 ; \n \u2014C(\u2550O)-cyclobutyl, unsubstituted or mono- or disubstituted with substituents independently of one another selected from the group consisting of \u2014F, \u2014Cl, \u2014Br, \u2014CH 3 , \u2014CF 3 , \u2014CN and \u2014OCH 3 ; \n \u2014C(\u2550O)-2-tetrahydrofuranyl, unsubstituted; \n \u2014C(\u2550O)-(5- to 6-membered heteroaryl), wherein said 5- to 6-membered heteroaryl is selected from the group consisting of thiazolyl, pyrazolyl, oxazolyl and 1-oxa-2,4-diazolyl, 1,2,5-oxadiazolyl, isoxazolyl, isothiazolyl, wherein in each case said 5- to 6-membered heteroaryl is unsubstituted or mono- or disubstituted with substituents independently of one another selected from the group consisting of \u2014F, \u2014Cl, \u2014Br, \u2014CH 3 , \u2014CF 3 , \u2014CN, \u2550O, and \u2014OCH 3 ; \n \u2014S(\u2550O) 2 \u2014C 1-10 -alkyl, unsubstituted; \n \u2014S(\u2550O) 2 -cyclopropyl, unsubstituted; \n \u2014S(\u2550O) 2 \u2014CH 2- cyclopropyl, unsubstituted; or \n \u2014S(\u2550O) 2 -(5- to 6-membered heteroaryl), wherein said 5- to 6-membered heteroaryl is selected from the group consisting of thiazolyl, pyrazolyl, oxazolyl and 1-oxa-2,4-diazolyl, 1,2,5-oxadiazolyl, isoxazolyl, isothiazolyl, wherein in each case said 5- to 6-membered heteroaryl is unsubstituted or mono- or disubstituted with substituents independently of one another selected from the group consisting of \u2014F, \u2014Cl, \u2014Br, \u2014CH 3 , \u2014CF 3 , \u2014CN, \u2550O, and \u2014OCH 3 .

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.19444
- Patent Class: 546.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16223845', '14409133', '13522823', '13272079', '12307526']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8055555817230031
- 35 USC 102 Novelty (BERT): 0.5718062814530244
- Combined Prediction Score: 0.7821806516960053
- Mean Citation Score: 346.2803560000001
- Max Citation Score: 450.94534
- Similarity Product: 422.2762617363119

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test